The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response is a research paper published in Genes & Development (2022). On theSindex it has a DataRank of 0.529. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.529
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA125123
Cancer Prevention and Research Institute of Texas
Grant: RP170067
CPRIT-Multi-Investigator Research Award
Grant: RP160652-P3
NCI NIH HHS
Grant: P30 CA014236
NCI NIH HHS
Grant: R37 CA214609
NCI NIH HHS
Grant: P30 CA016672
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
National Institutes of Health
Grant: 5R37CA214609-07
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
Fundação para a Ciência e a Tecnologia, I.P.
Grant: Incentivo/SAU/LA0001/2013
Incentive - LA 1 - 2013
National Institutes of Health
Grant: 5P30CA014236-30
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 5R35CA197616-11
Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology
Rexanna's Foundation for Fighting Lung Cancer
NIH
CCSG
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 1 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 2 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 2 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 3 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 3 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 4 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Additional file 4 of Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma